对以合成致死性为导向的精密瘤学领域进行系统分析
Alejandro A Schäffer1, Youngmin Chung2, Ashwin V Kammula1
1Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Med (New York, N.Y.)
|January 13, 2024
概括
合成致死性 (SL) 是一种有前途的癌症治疗方法. 虽然许多SL相互作用已在临床前得到验证,但大多数尚未达到临床试验,这表明癌症治疗的未来潜力显著.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 合成致死性 (SL) 是一种基因相互作用,其中两个基因的失活会损害细胞.
- 自提出以来的25多年来,SL是针对癌症脆弱性的关键策略.
- SL研究已经扩展到DNA损伤反应 (DDR) 途径之外.
研究的目的:
- 综合评估合成致死性在瘤学中的影响和未来潜力.
- 分析SL在癌症治疗中的应用的临床前和临床场景.
主要方法:
- 在PubMed. 的系统文献综述.
- 来自Trialtrove的临床试验数据的分析.
- 确定临床前SL对和临床试验.
主要成果:
- 235个临床前验证的SL对被确定.
- 发现了1,207个SL相关的临床试验,持续增长.
- SL试验的成功率高于非SL试验.
- 75%的验证的SL相互作用尚未在临床试验中.
结论:
- SL是精密瘤学的关键驱动力.
- 利用SL有助于识别预测生物标志物和治疗点.
- SL促进了有效的组合疗法的开发.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


